AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05740462 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recipes consumption
Description: Participants will eat two recipes a day for 17 weeks
Study NCT03376984 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Gutta Percha
Description: Gutta percha is a device made from coagulated sap of certain tropical trees intended to fill the root canal of a tooth. The gutta percha is softened by heat and inserted into the root canal, where it hardens as it cools. Gutta percha is classified as Class I (general controls).
Study NCT03376984 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gutta Percha
Description: Gutta percha is a device made from coagulated sap of certain tropical trees intended to fill the root canal of a tooth. The gutta percha is softened by heat and inserted into the root canal, where it hardens as it cools. Gutta percha is classified as Class I (general controls).
Study NCT05740462 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Recipes consumption
Description: Participants will eat two recipes a day for 17 weeks
Study NCT05740462 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hydroponic unit
Description: Participants will grow vitamin B12 biofortified plants for 17 weeks and consume (10 grams) of plant material for 11 weeks.
Study NCT05740462 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Hydroponic unit
Description: Participants will grow vitamin B12 biofortified plants for 17 weeks and consume (10 grams) of plant material for 11 weeks.
Study NCT04691869 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Achilles EXPII
Description: Portable ultrasound machine that measures a patient's bone density at the calcaneus.
Study NCT05659290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib alternating with Bevacizumab plus Capecitabine
Description: Maintenance therapy with Fruquintinib 5mg, orally, once daily, d1-14, 2 weeks on/ 1 week off, q3w, followed by Bevacizumab 7.5 mg/kg, iv.gtt,d1,q3w + Capecitabine 850 mg/m2, orally, twice daily, d1-14, q3w; every 6 weeks as a treatment cycle; until unacceptable toxicity, withdrawal of informed consent, death, or other criteria for ending the study (whichever occurs earlier).
Study NCT05659290 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab plus Capecitabine
Description: Maintenance therapy with Bevacizumab 7.5 mg/kg, iv.gtt,d1,q3w + Capecitabine 850 mg/m2, orally, twice daily, d1-14, q3w; every 3 weeks as a treatment cycle; until unacceptable toxicity, withdrawal of informed consent, death, or other criteria for ending the study (whichever occurs earlier).
Study NCT04931511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound betamethasone Injection(Gluteal muscle injection)
Description: Gluteal muscle injection(Compound betamethasone 1ml + Sodium Chloride Injection 4ml) + Subacromial Ultrasound Guided injection(Sodium Chloride Injection 5ml)
Study NCT04931511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound betamethasone Injection(Subacromial Ultrasound Guided injection)
Description: Gluteal muscle injection (Sodium Chloride Injection 5ml)+ Subacromial Ultrasound Guided injection (corticosteroid 1ml+Sodium Chloride Injection 4ml)
Study NCT04931511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical therapy
Description: paticipant will be teached by the Physicaltherapist to reduce the shoulder pain at home
Study NCT06584721 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anti-pronation taping (Low dye taping) + Conventional therapy
Description: They would be receiving treatment as follow:~Anti-pronation taping (Low dye taping) Applied on alternate days. 3 days / week for 4 weeks.~Conventional Therapy includes 1. Tens biphasic mode, 90Hz, 100ms pulse width for 20 mins 2. William flexion exercises (5repsx1set). 3. Lower limb stretching exercises (3repsxset1, 10sec hold) 3sessions/ week.
Study NCT06584721 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Short Foot Exercises + Conventional PT
Description: They would be receiving treatment as follow:~Short foot exercises are used to reduce the foot pronation: Frequency: 30 reps x 1 set, 30 sec hold and 10 sec relaxation for 4 weeks. 3 session/ week).~Short foot Exercises includes a four-week plan, 1- Shortening of foot in Anterior-posterior direction, 2- Increase medial longitudinal arch, 3- Balanced loading in standing, 4- Approximating Head of first, second meta-tarsal and calcaneus with patient in standing (single leg).~Conventional therapy includes 1. Tens biphasic mode, 90Hz, 100ms pulse width for 20 mins 2. William flexion exercises (5repsx1set). 3. Lower limb stretching exercises (3repsx1set, 10sec hold) 3sessions/ week.
Study NCT05623761 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BUCCOTHERM® Sensitive Gums with Fluoride
Description: Toothbrushing using standardised technique and pear-sized amount of toothpaste BUCCOTHERM® Sensitive Gums with Fluoride twice daily for 1 month.
Study NCT05623761 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BUCCOTHERM® Sensitive Gums Fluoride-Free
Description: Toothbrushing using standardised technique and pear-sized amount of toothpaste BUCCOTHERM® Sensitive Gums Fluoride-Free twice daily for 1 month.
Study NCT04655222 — intervention group
Intervention type: DRUG
Intervention: Interferon Beta Therapy
Description: Administered as specified in the treatment arm.
Study NCT05168774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elamipretide
Description: Elamipretide is a tetra peptide with limited blood brain barrier penetration being developed for use in a variety of mitochondrial disorders, including FRDA, mitochondrial myopathy and Barth Syndrome.
Study NCT04127968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin A
Description: Children in intervention group will receive 50,000 IU vitamin A after being randomized.
Study NCT04127968 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oil
Description: Children in control group will receive equal volume of oil.
Study NCT06219811 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Two implant -retained overdenture reinforced with Co-Cr framework
Description: The intervention is made from polymethylmethacrylate reinforced with cobalt chromium ( Co-Cr) framework.
Study NCT06219811 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Two implant -retained overdenture reinforced with PEEK framework
Description: The intervention is made from polymethylmethacrylate reinforced with Polyetherketoneketone ( PEEK) framework.
Study NCT05315037 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Resistance Training
Description: Bench press: Exercise performed with participant lying supine with hands in prone position. Barbell is lowered vertically from fully extended elbow position to sternum, then returned to starting position. Barbell will be weighted with plates dependent on their strength and workout demands.~Deadlift: Consists of gripping bar while in a squat position. Extension of ankles, knees, and hips while gripping the bar brings the weight up until joints are locked completing the exercise concentric portion. The eccentric lowering of the weight follows and consists of flexion of joints.~Seated overhead press machine: This multi-joint exercise, deltoid and trapezius are the prime movers and triceps are secondary movers, with hands on the grips and a position allowing back and buttocks to be completely supported. They push against a load vertically until glenohumeral joint fully extends, then load is returned to starting position and process continues until all repetitions desired are achieved
Study NCT05338840 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MULLIGAN ROTATIONAL MOVEMENT
Description: 12 sessions over 6 weeks
Study NCT05338840 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medial gapping technique
Description: 12 sessions over 6 weeks
Study NCT05897281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SHOOT exercise group
Description: In addition to routine training, the experimental group will be done a progressive resistance band exercise program (SHOOT) created for shooters, 3 days a week for 8 weeks, accompanied by a physiotherapist.
Study NCT05897281 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: routine training group
Description: The control group will continue their routine training
Study NCT06149975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: motor-cognitive training
Description: The motor-cognitive training in this study will be conducted in form of a step-based dual-task training. A mat (approximately 90 x 90 cm) made from extra non-slip yoga mats is required. The mat is divided into 9 equal squares with a 3 x 3 pattern. Participants will be presented with stepping patterns which they must memorize and then execute on the mat in the pace given by a metronome. All participants will start at the same level. The progression will be adjusted individually according to the fixed criteria of the StepIt concept within the sessions. All sessions will be supervised by at least one physical therapist.
Study NCT04280692 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PfSPZ Challenge
Description: Aseptic, purified, cryopreserved Plasmodium falciparum sporozoites
Study NCT04280692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-Pyrimethamine
Description: Sub-curative 500mg/25mg single dose regimen
Study NCT05625906 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi-media experiential training programme
Description: 1. Webpage and mobile applications of training material on ACP, to be offered four weeks before the workshop~2. A three-hour multimedia workshop (8-10 nurses per group) including enhanced lectures and a role play encounter with standardised patients. Immediate feedback on their quality of decision support skills will be given. The workshops will be delivered by an experienced advance practice nurse with a palliative care specialty.~3. Writing a reflective journal after the role play with standardised patients
Study NCT06175819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manuka honey( MgO 850, UMF+20) loaded nano-formulation
Description: Assessment of the efficacy of manuka-loaded nano-formulation and manuka honey-loaded gel on the improvement of acne vulgaris
Study NCT06175819 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manuka honey( MgO 850, UMF+20) loaded nano-formulation
Description: Assessment of the efficacy of manuka-loaded nano-formulation and manuka honey-loaded gel on the improvement of acne vulgaris
Study NCT06539455 — intervention group
Intervention type: DRUG
Intervention: standard anti-TB treatment
Description: standard anti-TB treatment in line with international guidelines (isoniazid , rifampin, ethambutol, and pyrazinamide)
Study NCT04495673 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Description: Participants receive 10 sessions (2 5-visit blocks of 46 minutes) of active tDCS to DLPFC (dorsolateral prefrontal cortex)
Study NCT04495673 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sham Transcranial Direct Current Stimulation (tDCS)
Description: Participants receive 10 sessions (1 5-visit block of 46 minutes of active tDCS and 1 5-visit block of sham tDCS)
Study NCT04495673 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Training
Description: Executive functioning tasks
Study NCT04495673 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: Executive functioning tasks
Study NCT05807347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: VA regimen Drug: Venetoclax orally once daily (100 mg d1, 200 mg d2, 400 mg d3-21); Drug: Azacitidine 75 mg/m2 subcutaneously once daily on days 1-7. CAG regimen Drug: Cytarabine 10mg/m2 subcutaneously q12h on days 1-7 Drug: Aclacinomycin 12-14mg/m2 on days 1,3,5,7 Drug: Granulocyte colony-stimulating factor 5ug/kg on days 0-8, discontinue if WBC >20×109/L
Study NCT05006625 — intervention group
Intervention type: OTHER
Intervention: Collaborative Care Model
Description: Use of the collaborative care model to screen and deliver care for depression in adolescents and young adults aged 15-24 years seeking HIV prevention and treatment services
Study NCT05978323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief intervention
Description: Short face-to-face intervention interviews will be conducted with individuals in the intervention group. Interviews will be held in primary healthcare organizations' meeting rooms. Brief intervention interviews will be conducted with the intervention group. It was determined as the first evaluation and the follow-ups on the 1st day, 15th day, 1st month, 3rd month, and the last evaluation (6th month). Brief interventions, 5A for those who are ready to change their behavior (Ask, Advise, Assess, Assist, Arrange); Those who are not ready to change their behavior 5R (Relevance, Risks, Rewards, Roadblocks, Repetition) model will be used. Brief intervention interviews will take an average of 20-30 minutes. The talks will include awareness of overweight and obesity, a healthy diet, and exercise. By the researcher's prepared will be used for individuals with low health literacy educational materials.
Study NCT04743908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Social Network Strategy + COVID-19 messaging
Description: Contextually adapted and theory-driven messages - misinformation correction and self-affirmation - to increase awareness, self-efficacy and community engagement in our adapted Social Network testing Strategy (SNS). SNS is an evidence-based testing intervention that has been widely used in multiple settings with marginalized individuals (ie substance-users) who facilitate the recruitment of their social contacts into testing services.
Study NCT04896827 — intervention group
Intervention type: OTHER
Intervention: Conditioned pain modulation test
Description: Conditioned pain modulation (CPM) protocol consist of evaluating pain during a heat test, before and after one conditioning stimulus (cold water bath); 3 cameras will be capturing participants' facial expressions during the tests.
Study NCT04830163 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Brain state-dependent paired corticomotoneuronal stimulation (PCMS)
Description: Paired corticomotoneuronal stimulation (PCMS) involves delivering precisely timed pairs of transcranial magnetic stimulation (TMS) and peripheral nerve stimulation (PNS) so that the neuronal activity evoked by such stimulation arrives synchronously at corticospinal-motoneuronal synapses. This synchronous arrival is postulated to cause long-term potentiation via spike timing-dependent plasticity, which then improves corticospinal transmission and hand function. In this study, paired corticomotoneuronal stimulation (PCMS) will be applied during specific brain states that reflect increased recruitment of motoneurons via the corticospinal tract. This increased recruitment is expected to enhance the beneficial effects of PCMS on human hand function after stroke.
Study NCT04830163 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Brain state-dependent paired corticomotoneuronal stimulation (PCMS)
Description: Paired corticomotoneuronal stimulation (PCMS) involves delivering precisely timed pairs of transcranial magnetic stimulation (TMS) and peripheral nerve stimulation (PNS) so that the neuronal activity evoked by such stimulation arrives synchronously at corticospinal-motoneuronal synapses. This synchronous arrival is postulated to cause long-term potentiation via spike timing-dependent plasticity, which then improves corticospinal transmission and hand function. In this study, paired corticomotoneuronal stimulation (PCMS) will be applied during specific brain states that reflect increased recruitment of motoneurons via the corticospinal tract. This increased recruitment is expected to enhance the beneficial effects of PCMS on human hand function after stroke.
Study NCT05542836 — intervention group
Intervention type: BEHAVIORAL
Intervention: Expedited postoperative activity instructions
Description: Ad lib postoperative activity and return to work recommendations
Study NCT05542836 — intervention group
Intervention type: BEHAVIORAL
Intervention: Standard postoperative activity restructions
Description: Standard conservative postoperative activity and return to work recommendations
Study NCT06499870 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT06499870 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT04280692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piperaquine
Description: Sub-curative 480mg single dose regimen
Study NCT04280692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artemether lumefantrine
Description: Three day curative regimen 20mg/120mg
Study NCT04280692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Primaquine
Description: Single low dose regimen 0.25 mg base/kg
Study NCT04097054 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Augmented preoperative planning
Description: The study investigates the impact of augmented preoperative planning on OR time variance in complex and rare visceral surgical procedures.
Study NCT05018182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin 85 mg/m² Q2w(2 h) before surgery rection and 130 mg/m² Q3w (2 h) after surgery
Study NCT05018182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Irinotecan 150 mg/m² ivgtt(1.5 h) Q2w before surgery rection
Study NCT05018182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folinic Acid
Description: Folinic acid 400 mg/m² ivgtt(2 h) Q2w before surgery rection
Study NCT05018182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5FU
Description: 5-FU 2800 mg/m² civ(46 h) Q2w before surgery rection
Study NCT05018182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine 1000mg/m² d1-14 po Q3w after surgery rection
Study NCT04936763 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Janesse 20 (Cross-linked Hyaluronic Acid)
Description: Janesse 20 will be administered at baseline (visit 2, day 0) and, if the Investigator will evaluate necessary, also at day 30 (visit 3). The Investigational device will be injected with retrograde technique (moving backward) with homogeneous amount on the length of each side of Labia Majora. The Janesse 20 dosage administered will be 1 ml in left labia and 1 ml in right labia for each session.
Study NCT05391347 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Orange oil aromatherapy
Description: 5 minutes before the invasive procedure, 3 ml of orange oil were dripping onto the sponge, and the patient was told to breathe slowly at a distance of 3 cm and to smell during the process.
Study NCT04818151 — intervention group
Intervention type: DRUG
Intervention: Warfarin
Description: Warfarin treatment for VTE
Study NCT04818151 — intervention group
Intervention type: DRUG
Intervention: Apixaban
Description: Apixaban treatment for VTE
Study NCT05447429 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block
Description: TAP block will be performed by a needle which is punctured at the midaxillary line between subcostal margin and iliac crest, once tip of the needle had detected just above the peritoneum the syringe pulled back.
Study NCT05447429 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 20 ml saline solution will be injected by a needle which is punctured at the midaxillary line between subcostal margin and iliac crest, once tip of the needle had detected just above the peritoneum the syringe pulled back.
Study NCT04670029 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adapted physical activity
Description: APA sessions during chemotherapy with aerobic and anaerobic sessions on site and at home (+ home exercises book if the patient so wishes)
Study NCT05065580 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Osteopathic Manipulative Treatment
Description: Individuals will receive the following techniques during weekly OMT (osteopathic manipulative techniques) for a duration of 8 weeks: 1. Suboccipital release 2. Vault hold. 3. Soft tissue techniques at the cervical and shoulder region 4.There will be NO high velocity low amplitude (HVLA) techniques
Study NCT06647173 — intervention group
Intervention type: BEHAVIORAL
Intervention: Blued+ Service Platform
Description: During the intervention period, participants received the enhanced version of the Blued app. The free HIV prevention services were integrated into the Blued app: health messaging, in-home HIV testing, linkage to care for those testing HIV positive, condoms, lubricants, in-app screening, and provision to PrEP.
Study NCT06645522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Edaravone dexborneol
Description: Edaravone dexborneol injection 37.5mg (edaravone 30mg and dexborneol 7.5mg) and 100ml of 0.9% saline every 12 hours for 7 days; sequentially a sublingual dose of edaravone dexborneol 36 mg (edaravone, 30 mg; dexborneol, 6 mg) twice a day for 21 days.
Study NCT06645522 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo injection every 12 hours for 7 days; sequentially a sublingual dose of placebo drug twice a day for 21 days.
Study NCT06577012 — intervention group
Intervention type: PROCEDURE
Intervention: Small incision lenticule extraction
Description: Small incision lenticule extraction surgeries performed by two Refractive surgery experts (Refractive surgery expert 1: YYF, Associate Professor with 10 years of experience as a refractive surgeon; Refractive surgery expert 2: GF, Associate Professor with 5 years of experience as a refractive surgeon) and a Attending ophthalmologist (XJ, Attending ophthalmologist with 1 year of experience as a refractive surgeon).